This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guillou, L. Articles by Benhattar, J. Search for Related Content PubMed PubMed Citation Articles by Guillou, L. Articles by Benhattar, J.

American Journal of Pathology, Vol 149, 1221-1228, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Germ cell tumors of the testis overexpress wild-type p53

L Guillou, A Estreicher, P Chaubert, J Hurlimann, AM Kurt, G Metthez, R Iggo, AC Gray, P Jichlinski, HJ Leisinger and J Benhattar
University Institute of Pathology of Lausanne, Switzerland.

Several recent studies have suggested that testicular germ cell tumors express high levels of wild-type p53 protein. To clarify and confirm this unexpected result, we have investigated seminomatous and nonseminomatous germ cell tumors at the genomic, mRNA, and protein levels. Thirty-five tumors were examined for p53 overexpression using antibodies directed against the p53 (PAb1801, PAb240, and CM1), mdm2 (IF2), and p21Waf1/Clp1 (EA10) proteins. Thirty-two tumors were screened for p53 mutations by single-strand conformation polymorphism analysis. Eighteen tumors were screened with a functional assay that tests the transcriptional competence of human p53 protein expressed in yeast. On frozen sections, 100, 65, 35, 73, and 0% of tumors reacted with the CM1, PAb240, PAb1801, IF2, and EA10 antibodies, respectively. No p53 mutations were detected by single-strand conformation polymorphism or by functional assay. The fact that many tumors overexpress wild-type p53 but not mdm2 rules out mdm2 overexpression as a general explanation for the presence of wild-type p53 in these tumors. The absence of p21 overexpression suggests that p53 may be unable to activate transcription of critical target genes, which may explain why the presence of wild-type p53 is tolerated in this tumor type, although the mechanism for this transcriptional inactivity remains to be established.

This article has been cited by other articles:

				T. M. Said, U. Paasch, H.-J. Glander, and A. Agarwal Role of caspases in male infertility Hum. Reprod. Update, January 1, 2004; 10(1): 39 - 51. [Abstract] [Full Text] [PDF]

				D. W. Brandli, T. M. Ulbright, R. S. Foster, O. W. Cummings, S. Zhang, C. J. Sweeney, J. N. Eble, and L. Cheng Stroma Adjacent to Metastatic Mature Teratoma after Chemotherapy for Testicular Germ Cell Tumors Is Derived from the Same Progenitor Cells as the Teratoma Cancer Res., September 15, 2003; 63(18): 6063 - 6068. [Abstract] [Full Text] [PDF]

				A.-M. F. Kersemaekers, F. Mayer, M. Molier, P. C. van Weeren, J. W. Oosterhuis, C. Bokemeyer, and L. H.J. Looijenga Role of P53 and MDM2 in Treatment Response of Human Germ Cell Tumors J. Clin. Oncol., March 15, 2002; 20(6): 1551 - 1561. [Abstract] [Full Text] [PDF]

				D. Migliorini, D. Danovi, E. Colombo, R. Carbone, P. G. Pelicci, and J.-C. Marine Hdmx Recruitment into the Nucleus by Hdm2 Is Essential for Its Ability to Regulate p53 Stability and Transactivation J. Biol. Chem., February 22, 2002; 277(9): 7318 - 7323. [Abstract] [Full Text] [PDF]

				M. Iwato, O. Tachibana, Y. Tohma, Y. Arakawa, H. Nitta, M. Hasegawa, J. Yamashita, and Y. Hayashi Alterations of the INK4a/ARF Locus in Human Intracranial Germ Cell Tumors Cancer Res., April 1, 2000; 60(8): 2113 - 2115. [Abstract] [Full Text]

				R. Stad, Y. F. M. Ramos, N. Little, S. Grivell, J. Attema, A. J. van der Eb, and A. G. Jochemsen Hdmx Stabilizes Mdm2 and p53 J. Biol. Chem., September 1, 2000; 275(36): 28039 - 28044. [Abstract] [Full Text] [PDF]

				A. J. Muller, A. K. Teresky, and A. J. Levine A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13 PNAS, July 18, 2000; 97(15): 8421 - 8426. [Abstract] [Full Text] [PDF]